Global benchmarks in primary robotic bariatric surgery redefine quality standards for Roux-en-Y gastric bypass and sleeve gastrectomy
Guillaume Giudicelli,Daniel Gero,Lind Romulo,Vasu Chirumamilla,Pouya Iranmanesh,Christopher K Owen,Wayne Bauerle,Amador Garcia,Lisa Lucas,Anne-Sophie Mehdorn,Dhananjay Pandey,Abdullah Almuttawa,Francisco Cabral,Abhishek Tiwari,Virginia Lambert,Beniamino Pascotto,Celine De Meyere,Marouan Yahyaoui,Thomas Haist,Oliver Scheffel,Maud Robert,Frederiek Nuytens,Santiago Azagra,Lilian Kow,Arun Prasad,Carlos Vaz,Michel Vix,Vivek Bindal,Jan H Beckmann,David Soussi,Ramon Vilallonga,Maher El Chaar,Erik B Wilson,Arif Ahmad,Andre Teixeira,Monika E Hagen,Christian Toso,Pierre-Alain Clavien,Milo Puhan,Marco Bueter,Minoa K Jung
DOI: https://doi.org/10.1093/bjs/znad374
2024-01-03
Abstract:Background: Whether the benefits of the robotic platform in bariatric surgery translate into superior surgical outcomes remains unclear. The aim of this retrospective study was to establish the 'best possible' outcomes for robotic bariatric surgery and compare them with the established laparoscopic benchmarks. Methods: Benchmark cut-offs were established for consecutive primary robotic bariatric surgery patients of 17 centres across four continents (13 expert centres and 4 learning phase centres) using the 75th percentile of the median outcome values until 90 days after surgery. The benchmark patients had no previous laparotomy, diabetes, sleep apnoea, cardiopathy, renal insufficiency, inflammatory bowel disease, immunosuppression, history of thromboembolic events, BMI greater than 50 kg/m2, or age greater than 65 years. Results: A total of 9097 patients were included, who were mainly female (75.5%) and who had a mean(s.d.) age of 44.7(11.5) years and a mean(s.d.) baseline BMI of 44.6(7.7) kg/m2. In expert centres, 13.74% of the 3020 patients who underwent primary robotic Roux-en-Y gastric bypass and 5.9% of the 4078 patients who underwent primary robotic sleeve gastrectomy presented with greater than or equal to one complication within 90 postoperative days. No patient died and 1.1% of patients had adverse events related to the robotic platform. When compared with laparoscopic benchmarks, robotic Roux-en-Y gastric bypass had lower benchmark cut-offs for hospital stay, postoperative bleeding, and marginal ulceration, but the duration of the operation was 42 min longer. For most surgical outcomes, robotic sleeve gastrectomy outperformed laparoscopic sleeve gastrectomy with a comparable duration of the operation. In robotic learning phase centres, outcomes were within the established benchmarks only for low-risk robotic Roux-en-Y gastric bypass. Conclusion: The newly established benchmarks suggest that robotic bariatric surgery may enhance surgical safety compared with laparoscopic bariatric surgery; however, the duration of the operation for robotic Roux-en-Y gastric bypass is longer.